Repositorio Dspace

Listar por autor "Baca-García, Enrique"

Listar por autor "Baca-García, Enrique"

Ordenar por:Orden:Resultados:

  • Long-term effectiveness, adherence and safety of twice-yearly paliperidone-palmitate long acting-injectable in patients with schizophrenia in Europe: 2-year mirror-image data from the paliperdone-2 per year study (P2Y) 
    Manchado-Perero, Sofía; Rodríguez-Lorente, Ana; García-Pérez, Alba-María; García, Guillermo-Isidro; Forcén-Muñoz, Luis-Alberto; Ovejero-García, Sanitago; Sáez-Povedano, Rocío; González-Galdámez, Ana-Luisa; Mata-Iturralde, Laura; Ramírez-Bonilla, Mariluz; Fuentes-Pérez, Paloma; Ovejas-Catalán, Claudia; Suárez-Pinilla, Paula; Fernández-Abascal, Blanca; Omana-Colmenares, Miguel; Campos-Navarro, María-Pilar; Baca-García, Enrique; Lara-Fernández, Ana; Benavente-López, Sergio; Raya-Platero, Alberto; Barberán-Navalon, Miguel; Sánchez-Alonso, Sergio; Vázquez-Bourgon, Javier; Pappa, Sofia; García-Carmona, Juan-Antonio (FRONTIERS MEDIA SA, 2025-03-04)
    BACKGROUND: LAIs with longer dosing intervals appear to be associated with improved clinical outcomes and added real-world benefits in the management of schizophrenia. Paliperidone palmitate six-monthly (PP6M) LAI provides ...
  • One-Year Evaluation of Paliperidone Palmitate 6-Monthly: Satisfaction and Perceived Effectiveness Among Patients, Relatives, and Clinicians 
    Manchado-Perero, Sofía; Rodríguez-Lorente, Ana; García-Pérez, Alba-María; García, Guillermo-Isidro; Forcén-Muñoz, Luis-Alberto; Ovejero, Santiago; Sáez-Povedano, Rocío; González-Galdámez, Ana-Luisa; Mata-Iturralde, Laura; Ramírez-Bonilla, Mariluz; Fuentes-Pérez, Paloma; Ovejas-Catalán, Claudia; Suárez-Pinilla, Paula; Fernández-Abascal-Puente, Blanca; Colmenares, Miguel-Omana; Campos-Navarro, María-Pilar; Baca-García, Enrique; Lara-Fernández, Ana; Benavente-López, Sergio; Raya-Platero, Alberto; Barberán-Navalon, Miguel; Sánchez-Alonso, Sergio; Vázquez-Bourgon, Javier; Pappa, Sofia; García-Carmona, Juan-Antonio (DOVE MEDICAL PRESS LTD, 2025-05)
    BACKGROUND: Patient satisfaction and perceived treatment effectiveness play a critical role in healthcare outcomes and overall well-being. Understanding patient experiences can help identify barriers to adherence and guide ...
  • Preliminary data from a 4-year mirror-image and multicentre study of patients initiating paliperidone palmitate 6-monthly long-acting injectable antipsychotic: the Paliperidone 2 per Year study 
    García-Carmona, Juan-Antonio; García-Pérez, Alba; Isidro-García, Guillermo; Forcen-Muñoz, Luis-Alberto; Ovejero-García, Santiago; Saez-Povedano, Rocío; González-Galdamez, Ana-Luisa; Mata-Iturralde, Laura; Hernández-Sánchez, Fernando; Ramírez-Bonilla, Mariluz; Fuentes-Pérez, Paloma; Ovejas-Catalán, Claudia; Suárez-Pinilla, Paula; Valdivia-Muñoz, Francisco; Fernández-Abascal, Blanca; Omana-Colmenares, Miguel; Martín-Pérez, Ángela-de-Lourdes; Campos-Navarro, María-Pilar; Baca-García, Enrique; Benavente-López, Sergio; Raya-Platero, Alberto; Barberan-Navalon, Miguel; Sánchez-Alonso, Sergio; Vázquez-Bourgon, Javier; Pappa, Sofia (SAGE PUBLICATIONS LTD, 2023)
    BACKGROUND: Paliperidone palmitate 6-monthly (PP6M) is the first long-acting antipsychotic injectable (LAI) to allow for only two medication administrations per year, though there is presently limited insight into its ...